Annual Report - Investor Centre | AFT Pharmaceuticals
View
2
Download
0
Category
Documents
Report
Preview:
Click to see full reader
Citation preview
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Recommended
Addex Pharmaceuticals Investor Presentation September 2010
Documents
Addex Pharmaceuticals Investor Presentation July 2010
Documents
ACTELION’S CARDIOVASCULAR PIPELINE INVESTOR WEBCAST · © 2016 Actelion Pharmaceuticals Ltd PULMONARY AND SYSTEMIC CIRCULATION PATHWAYS 4 07 Nov 2016 Investor webcast
Documents
Investor Day - Alexion Pharmaceuticals, Inc
Documents
BAFNA PHARMACEUTICALS LIMITEDbafnapharma.com/pdf/NOTICE-OF-21st-AGM.pdf · BAFNA PHARMACEUTICALS LIMITED CIN ... the shareholders may also send requests to the Company‟s investor
Documents
INVESTOR PRESENTATION MAY 2019INVESTOR PRESENTATION MAY 2019 Important Notice 2 This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general
Documents
Investor Day - Genomic Vision › ... › Genomic-Vision-Investor... · Erwan Martin, MBA CFO • Previously with Cytomics Pharmaceuticals (CFO) and Syndex (French audit company)
Documents
AFT PHARMACEUTICALS - ASX · June 2016. 5. ACCELERATING CLINICAL STUDY PROGRAM • 12 studies across the AFT portfolio • 1500+ patients • 7 countries - Australia, Jordan, Mexico,
Documents
Addex Pharmaceuticals Investor Relations Presentation October 2009
Documents
Symposium Investor Roadshow November 2015 - MGC Pharmaceuticals
Investor Relations
INVESTOR UPDATEaarti-industries.com/media/investors/presentations/...•Leading manufacturer of Speciality Chemicals & Pharmaceuticals with diversified end-uses in Pharmaceuticals,
Documents
Investor Presentation May 7, 2013 ISIS PHARMACEUTICALS
Documents
Addex Pharmaceuticals Investor Presentation June 2010
Documents
AFT PHARMACEUTICALS · 2018. 8. 6. · This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general overview of AFT. It is not prepared for
Documents
DISHMAN PHARMACEUTICALS & CHEMICALS LIMITED Q1 … · DISHMAN PHARMACEUTICALS & CHEMICALS LIMITED Q1 FY15 QUARTERLY INVESTOR ... Q1 FY15 RESULTS BUSINESSWISE ANALYSIS ... Process
Documents
AFT PHARMACEUTICALS · Investor Presentation May 2016 1 IMPORTANT NOTICE This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general overview
Documents
Addex Pharmaceuticals Investor Presentation April 2010
Documents
Amphastar Pharmaceuticals, Inc. - Jefferies - The Global ... · Amphastar Pharmaceuticals, Inc. Investor Presentation . June 2015 . CONFIDENTIAL 1 ... Acquired Merck’s insulin API
Documents
Valeant Pharmaceuticals International (VRX) Earnings ... · The following Valeant Pharmaceuticals International conference call took place ... , everyone. Welcome to Valeant's investor
Documents
Addex Pharmaceuticals Investor Presentation July 2010
Documents